New drug MAR001 targets high triglycerides in early trial
NCT ID NCT05896254
First seen Nov 14, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This early-stage study tested the safety and tolerability of a new drug called MAR001 in 55 adults with high triglycerides (a type of fat in the blood). The main goal was to see if the drug is safe, and researchers also checked whether it lowers triglyceride levels. The study was completed, but results have not been released yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brisbane Site
Brisbane, 4006, Australia
-
Melbourne Site
Melbourne, 3004, Australia
Conditions
Explore the condition pages connected to this study.